Farletuzumab ecteribulin, CAS [[2407465-18-1]]

Produktübersicht

• Artikelname: Farletuzumab ecteribulin, CAS [[2407465-18-1]]
• Artikelnummer: MCE-HY-P99612
• Hersteller Artikelnummer: HY-P99612
• Alternativnummer: MCE-HY-P99612-1MG,MCE-HY-P99612-5MG,MCE-HY-P99612-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: MORAb-202

Produktbeschreibung

Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.

Produkteigenschaften

• Molekulargewicht: 149000 (average)
• Reinheit: 99.40
• CAS Nummer: [2407465-18-1]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: ADC Related